Logo
Register Log in
FirstArticle-BlurbImagePath
AGA Accepting Applications for Its Inaugural Incubator Program

AUGUST 21, 2025

FirstArticle-BlurbImagePath
Wegovy Approved to Treat MASH With Moderate to Advanced Fibrosis

AUGUST 20, 2025

FirstArticle-BlurbImagePath
Highlights From DDW 2025, Part 2

AUGUST 19, 2025

Email This Article
POSTED: SEPTEMBER 3, 2024

Vancomycin Linked to IBD Remission in Patients With Primary Sclerosing Cholangitis

Children with primary sclerosing cholangitis–associated inflammatory bowel disease may benefit from prolonged courses of vancomycin, a recent retrospective study concluded.
A link to this article will be included in this email.
Recipient's Email Address:
Enter email addresses separated by commas if sending to more than one person. (200 characters max)
Your Name:
Your Email Address:


Personal Message: (Optional)
These email addresses will only be used to send out this message.
Please wait.. Please wait..

Pediatric GI

SEPTEMBER 3, 2024

Vancomycin Linked to IBD Remission in Patients With Primary Sclerosing Cholangitis

Related Content

Early Anti-TNF Treatment Pivotal in Preventing Perianal Fistula in Pediatric Crohn’s Disease

Early administration of


To read the full story, Log in or Sign up for a Free Account

Log in / Sign up

Check out our new Clinical tab!

We've added an exciting new feature to our website. Click on "Clinical" in the navbar to explore!

The following result is from the NPI Registry Public Search database. You can click on the NPI number to view detailed information and verify its accuracy. If your NPI is not found in this search, you can try searching again using the form below. If you have difficulty finding your NPI number please contact us at web@mcmahonmed.com
OR

NPI Name Organization/ Institution State Zip Code Taxonomy    Credential Select